BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23010217)

  • 1. Probiotic Lactobacillus reuteri strains ATCC PTA 5289 and ATCC 55730 differ in their cariogenic properties in vitro.
    Jalasvuori H; Haukioja A; Tenovuo J
    Arch Oral Biol; 2012 Dec; 57(12):1633-8. PubMed ID: 23010217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Lactobacillus reuteri PTA 5289 and L. paracasei DSMZ16671 on the adhesion and biofilm formation of Streptococcus mutans.
    Marttinen AM; Haukioja AL; Keskin M; Söderling EM
    Curr Microbiol; 2013 Aug; 67(2):193-9. PubMed ID: 23503788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
    Söderling EM; Marttinen AM; Haukioja AL
    Curr Microbiol; 2011 Feb; 62(2):618-22. PubMed ID: 20835828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study.
    Keller MK; Hasslöf P; Stecksén-Blicks C; Twetman S
    Acta Odontol Scand; 2011 Sep; 69(5):263-8. PubMed ID: 21306197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
    Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
    BMC Microbiol; 2021 Oct; 21(1):271. PubMed ID: 34615458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study.
    Twetman L; Larsen U; Fiehn NE; Stecksén-Blicks C; Twetman S
    Acta Odontol Scand; 2009; 67(5):284-8. PubMed ID: 19479452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans.
    Wasfi R; Abd El-Rahman OA; Zafer MM; Ashour HM
    J Cell Mol Med; 2018 Mar; 22(3):1972-1983. PubMed ID: 29316223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
    Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
    Oral Health Prev Dent; 2020 Nov; 18():1017-1023. PubMed ID: 33215493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between Lactobacillus rhamnosus GG and oral micro-organisms in an in vitro biofilm model.
    Jiang Q; Stamatova I; Kainulainen V; Korpela R; Meurman JH
    BMC Microbiol; 2016 Jul; 16(1):149. PubMed ID: 27405227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
    Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
    PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriological effects of a Lactobacillus reuteri probiotic on in vitro oral biofilms.
    Madhwani T; McBain AJ
    Arch Oral Biol; 2011 Nov; 56(11):1264-73. PubMed ID: 21570060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and Characterisation of Probiotics for Antagonising the Cariogenic Bacterium Streptococcus mutans and Preventing Biofilm Formation.
    Lin PP; Hsieh YM; Tsai CC
    Oral Health Prev Dent; 2018; 16(5):445-455. PubMed ID: 30460358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Effect of
    Kim YJ; Lee SH
    J Microbiol Biotechnol; 2016 Nov; 26(11):1829-1835. PubMed ID: 27435538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics.
    Saha S; Tomaro-Duchesneau C; Rodes L; Malhotra M; Tabrizian M; Prakash S
    Benef Microbes; 2014 Dec; 5(4):447-60. PubMed ID: 25006013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of
    Borrell García C; Ribelles Llop M; García Esparza MÁ; Flichy-Fernández AJ; Marqués Martínez L; Izquierdo Fort R
    Int J Immunopathol Pharmacol; 2021; 35():20587384211031107. PubMed ID: 34325540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of probiotic Lactobacillus supernatants from the oral cavity on Streptococcus mutans biofilms.
    Rossoni RD; Velloso MDS; de Barros PP; de Alvarenga JA; Santos JDD; Santos Prado ACCD; Ribeiro FC; Anbinder AL; Junqueira JC
    Microb Pathog; 2018 Oct; 123():361-367. PubMed ID: 30053602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen Peptide in a Combinatorial Treatment with
    Jung HY; Cai JN; Yoo SC; Kim SH; Jeon JG; Kim D
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence capacities of oral lactobacilli for potential probiotic purposes.
    Samot J; Lebreton J; Badet C
    Anaerobe; 2011 Apr; 17(2):69-72. PubMed ID: 21514395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659.
    Sendelius M; Axelsson J; Liu P; Roos S
    J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37974056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
    Romani Vestman N; Hasslöf P; Keller MK; Granström E; Roos S; Twetman S; Stecksén-Blicks C
    Caries Res; 2013; 47(4):338-45. PubMed ID: 23486236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.